BIOVENTUS ($BVS) posted quarterly earnings results for Q1 2026 on Wednesday, May 6th. The company reported earnings of $0.15 per share, beating estimates of $0.10 by $0.05. The company also reported revenue of $132,090,000, beating estimates of $131,147,995 by $942,005.
You can see Quiver Quantitative's $BVS stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
BIOVENTUS Insider Trading Activity
BIOVENTUS insiders have traded $BVS stock on the open market 3 times in the past 6 months. Of those trades, 0 have been purchases and 3 have been sales.
Here’s a breakdown of recent trading of $BVS stock by insiders over the last 6 months:
- MICHELLE MCMURRY-HEATH has made 0 purchases and 2 sales selling 29,701 shares for an estimated $236,693.
- GUY P NOHRA sold 10,000 shares for an estimated $75,658
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API.
BIOVENTUS Hedge Fund Activity
We have seen 84 institutional investors add shares of BIOVENTUS stock to their portfolio, and 53 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- DIVISADERO STREET CAPITAL MANAGEMENT, LP removed 512,386 shares (-73.7%) from their portfolio in Q4 2025, for an estimated $3,812,151
- HILLSDALE INVESTMENT MANAGEMENT INC. added 401,230 shares (+148.7%) to their portfolio in Q1 2026, for an estimated $3,663,229
- ESSEX INVESTMENT MANAGEMENT CO LLC added 387,886 shares (+inf%) to their portfolio in Q4 2025, for an estimated $2,885,871
- MEROS INVESTMENT MANAGEMENT, LP added 315,160 shares (+inf%) to their portfolio in Q4 2025, for an estimated $2,344,790
- AMERICAN CENTURY COMPANIES INC removed 243,297 shares (-22.3%) from their portfolio in Q4 2025, for an estimated $1,810,129
- WEDGE CAPITAL MANAGEMENT L L P/NC added 241,826 shares (+inf%) to their portfolio in Q1 2026, for an estimated $2,207,871
- NANTAHALA CAPITAL MANAGEMENT, LLC added 236,741 shares (+4.1%) to their portfolio in Q4 2025, for an estimated $1,761,353
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API.
BIOVENTUS Government Contracts
We have seen $19,980 of award payments to $BVS over the last year.
Here are some of the awards which we have have seen pay out the most over the last year:
To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard.
BIOVENTUS Price Targets
Multiple analysts have issued price targets for $BVS recently. We have seen 2 analysts offer price targets for $BVS in the last 6 months, with a median target of $15.0.
Here are some recent targets:
- Alexander Nowak from Craig-Hallum set a target price of $16.0 on 03/06/2026
- Michael Petusky from Barrington Research set a target price of $14.0 on 03/06/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
Check out the Quiver Quantitative API to build on top of data on congressional stock trading, insider transactions, hedge fund moves, and more.
